



A venture debt warrant gives the lender the right to buy a small amount of your company's stock, usually at your last round's price, for up to about 10 years. Lenders size it as warrant coverage, a percentage of the loan: listed US venture lenders disclose ranges of roughly 2% to 20% of the loan amount. For a typical loan, that works out to about 0.5% to 2% of the company, around a tenth of the dilution of raising the same money as equity. The catch is that the cost grows with your success, can double if coverage is based on the full facility rather than what you draw, and lasts long after the loan is repaid.
This guide explains how warrants work, runs the numbers on one example company, and lists what to negotiate. For the wider picture on pricing and covenants, see venture debt explained.
A warrant is a contract that lets the holder buy a set number of shares at a fixed price (the strike or exercise price) before an expiry date. Until the lender exercises it, the lender owns no shares, has no vote and receives no dividends.
Lenders take warrants because venture loans are risky. They lend to companies that are usually unprofitable, their return from interest is capped, and a single failure can wipe out a loan. The warrant gives them a small share of the winners to make up for the losers. Listed lenders such as Hercules Capital and Runway Growth Finance describe warrants as a secondary source of return, after interest and fees.
Coverage is the dollar value of stock the lender can buy, quoted as a percentage of the loan. The number of warrant shares is the loan amount times the coverage percentage, divided by the strike price. Here is what listed US venture lenders told the SEC in their 2025 annual reports:
Banks generally ask for less coverage than specialist debt funds, and earlier-stage or riskier companies pay more. No public dataset compares the two directly, so treat any single "market rate" with care.
Why you see both "0.5% to 2%" and "5% to 20%": the two figures measure different things. One is a percentage of the loan; the other is a percentage of the company. To convert, multiply the coverage by the loan and divide by the post-money valuation. A $5 million loan at 10% coverage on a $50 million post-money company is $500,000 divided by $50 million, or about 1% of the company. Always ask a lender to state coverage three ways: in dollars, as a share count and as a percentage of fully diluted shares.
Most lender warrants are over your latest preferred series. Horizon Technology Finance, for example, reports that its warrants are predominantly in preferred stock. Once exercised, preferred shares carry that series' liquidation preference and price-based anti-dilution protection. Common stock carries neither, so a warrant over common is cheaper for founders.
Lender warrants usually last 5 to 10 years, and 10 is common. Hercules says its warrants stay exercisable for five to ten years, or three to five years after an IPO, whichever is shorter. Loans typically run three to four years, so the warrant outlives the loan: repaying early ends the interest, not the warrant.
After the coverage percentage itself, the biggest swing factor is what coverage is based on. Some lenders base it on the full facility and earn it all at signing. Others take a block at signing and more as each tranche is drawn, and some use drawn amounts only. Cooley's venture debt term sheet guide lists this as one of the key warrant questions to settle.
Put rights, minimum-return clauses or a "make-whole" on the warrant are not standard in US bank or debt fund forms. They turn the warrant into a future cash obligation, so treat them as a red flag.
Assume a company with 25,000,000 fully diluted shares, a Series A price of $2.00 and a $50 million post-money valuation. The founders hold 10,000,000 shares (40%). It borrows $5 million with 10% warrant coverage on the amount drawn, at a $2.00 strike.
The equity route dilutes about nine times more. But the loan must be repaid in cash with interest and fees, and it carries default risk that equity does not. For context, startups on Carta gave up a median of about 16% of the company per priced round from seed to Series C in 2025 (Carta, State of Private Markets: 2025 in Review).
At the same 3x exit, the 2,500,000 equity shares would be worth $15 million, against $1 million for the warrant.
Now assume a $10 million facility of which only $5 million is drawn. If coverage is based on the full commitment, the lender gets $1,000,000 of coverage: 500,000 shares, or 1.96% of the company, double the drawn-basis warrant. At a 3x exit that is $2,000,000 instead of $1,000,000, for money the company never borrowed.
Assume a 36-month interest-only loan at 12%, a 1% upfront fee and a 4% end-of-term payment, with any exit in year 3. These figures are illustrative, not market quotes.
A warrant adds less than one percentage point a year at a typical value, several points in a strong exit, and much more if coverage is based on money you never drew.
In 2017, Roku issued Silicon Valley Bank warrants to buy 408,648 Series H preferred shares at $9.1734 a share, its 2015 Series H price, in connection with a loan facility of up to $40 million (Roku 2017 Form 10-K). That is about $3.75 million of stock at the strike, roughly 9.4% coverage on the $40 million facility, with a ten-year term.
In rough order of value:
Coverage and interest rate trade against each other. If you expect a large outcome, a slightly higher rate with fewer warrants is usually cheaper, because the cost of a warrant grows with your success. Compare offers on total cost using the method in section 4. When several lenders compete, as in any competitive process, coverage is one of the easier terms to move.
UK lenders typically take warrants over the same class of share and at the same price as the last equity round, sized as a modest percentage of the loan and lasting around 10 years. UK warrant instruments also need shareholders to waive pre-emption rights and directors to have authority to allot shares, so check both before signing. The European Investment Bank's venture debt can combine warrants with interest, payment-in-kind interest or royalties, and its warrants may be sold back to the company after several years, which is a future cash cost to plan for.
It is the dollar value of stock a lender can buy through its warrant, stated as a percentage of the loan. On a $5 million loan at 10% coverage, the lender can buy $500,000 of stock at the strike price, usually your last round's price.
At signing, usually about 0.5% to 2% of the company. The real cost depends on the exit: at 3x the strike, the warrant on a $5 million loan with 10% coverage is worth $1 million to the lender, while below the strike it costs nothing.
Not entirely. It is minimally dilutive. Warrants count in your fully diluted shares from day one and dilute when exercised, though far less than an equity round of the same size. The loan must also be repaid with interest.
Usually the latest preferred series, at that round's price. Some lenders take common stock, and some warrants let the lender choose next-round preferred.
In a cash or public-stock deal, in-the-money warrants are typically net exercised automatically just before closing and underwater warrants expire. In a private-stock deal, the buyer may take them over. Check the warrant agreement.
Yes. Coverage, whether it is based on drawn or committed amounts, the strike, the class of stock, the term, step-ups and a success-fee alternative are all negotiable. Coverage usually trades against the interest rate.
As a separate line showing the class, number of shares, strike and expiry, included in fully diluted shares. That affects the next round's price per share and the size of any option pool top-up.
A venture debt warrant is a small, real piece of equity. At signing it usually costs well under 2% of the company, far less than an equity round, but its cost grows with your success and it outlives the loan. Read it in dollars, shares and fully diluted percentage, base it on what you actually draw, keep the strike at the last round price, and refuse step-ups, resets and put rights. Then compare the total cost of debt, warrants included, with the equity you would otherwise sell.
Global Capital Network connects founders with angels, family offices, VCs and lenders through our investor conferences and private investor dinners. Explore our glossary or get in touch to learn more.
This article is general information, not financial, legal, tax or accounting advice. Warrant and loan terms vary by lender and company. Have counsel and a finance advisor review any facility before you sign.